Monoclonal gammopathy of undetermined significance. Natural history in 241 cases, Am J Med, vol.64, pp.814-840, 1978. ,
URL : https://hal.archives-ouvertes.fr/hal-00945713
A long-term study of prognosis of monoclonal gammopathy of undetermined significance, N Engl J Med, vol.346, pp.564-573, 2002. ,
MGUS to myeloma: a mysterious gammopathy of underexplored significance, Blood, vol.128, pp.2599-606, 2016. ,
Long-term follow-up of monoclonal gammopathy of undetermined significance, New Engl J Med, vol.378, pp.241-250, 2018. ,
Smoldering multiple myeloma, N Engl J Med, vol.302, pp.1347-1356, 1980. ,
URL : https://hal.archives-ouvertes.fr/hal-00557757
International myeloma working group updated criteria for the diagnosis of multiple myeloma, Lancet Oncol, vol.15, pp.538-586, 2014. ,
Retrospective study of monoclonal gammopathies detected in the clinical laboratory of a Spanish healthcare district: 14-year series, Clin Chem Lab Med, vol.45, pp.190-196, 2007. ,
Myeloma Ig heavy chain V region sequences reveal prior antigenic selection and marked somatic mutation but no intraclonal diversity, J Immunol, vol.155, pp.2487-97, 1995. ,
Myeloma VL and VH gene sequences reveal a complementary imprint of antigen selection in tumor cells, Blood, vol.89, pp.219-245, 1997. ,
Clonal immunoglobulin against lysolipids in the origin of myeloma, N Engl J Med, vol.374, pp.555-61, 2016. ,
Antigen-mediated regulation in monoclonal gammopathies and myeloma, J Clin Invest Insight, vol.3, p.98259, 2018. ,
Hepatitis C virus, human herpesvirus 8, and the development of plasma-cell leukemia, J Clin Invest Insight, vol.2, pp.178-187, 2003. ,
Hepatitis C virus (HCV) infection, monoclonal immunoglobulin specific for HCV core protein, and plasma-cell malignancy, Blood, vol.112, pp.4357-4365, 2008. ,
Multiplexed infectious protein microarray immunoassay suitable for the study of the specificity of monoclonal immunoglobulins, Anal Biochem, vol.433, pp.202-211, 2013. ,
URL : https://hal.archives-ouvertes.fr/inserm-01401584
Global burden of cancers attributable to infections in 2012: a synthetic analysis, Lancet Glob Health, vol.4, issue.16, pp.30143-30150, 2016. ,
Origin and pathogenesis of B cell lymphomas, Methods Mol Biol, vol.971, pp.1-25, 2013. ,
Epstein-Barr virus-associated B-cell lymphomas: pathogenesis and clinical outcomes, Clin Cancer Res, vol.17, pp.3056-63, 2011. ,
Infection with hepatitis B and C viruses and risk of lymphoid malignancies in the European prospective investigation into cancer and nutrition (EPIC), Cancer Epidemiol Biomarkers Prev, vol.20, pp.208-222, 2011. ,
URL : https://hal.archives-ouvertes.fr/hal-00811971
Qualitative and quantitative analysis of human herpesvirus expression in chronic and acute B-cell lymphocytic leukemia and in multiple myeloma, Leukemia, vol.17, pp.185-95, 2003. ,
Proinflammatory state in MGUS and myeloma is characterized by low sialylation of pathogen-specific and other monoclonal and polyclonal immunoglobulin G. Front Immunol, vol.8, p.1347, 2017. ,
Immunoglobulin isotypes in multiple myeloma: laboratory correlates and prognostic implications in total therapy protocols, Br J Haematol, vol.145, pp.134-141, 2009. ,
Simple variables predict survival after autologous transplantation: a single centre experience in 181 multiple myeloma patients, Neoplasma, vol.54, pp.143-151, 2007. ,
Classification and prognostic evaluation in multiple myeloma. A retrospective study of relationship of survivals and responses to chemotherapy to immunological types, 20 single prognostic factors, 15 clinical staging systems, and 6 morphological classifications, Panminerva Med, vol.33, pp.93-110, 1991. ,
IgA type multiple myeloma, clinical features, and prognosis, Chinese Med J, vol.131, pp.1249-50, 2018. ,
Distinct immunogenetic signatures in IgA versus IgG multiple myeloma, 58th American Society of Hematology (ASH) Annual Meeting & Exposition, 2016. ,
Relationship between paraprotein clinical features in IgA polymerization and myeloma, Br J Haematol, vol.33, pp.117-147, 1976. ,
Clinical course and prognosis of smoldering (asymptomatic) multiple myeloma, New Engl J Med, vol.356, pp.2582-90, 2007. ,
Immunoblotting techniques for the detection of low level homogeneous immunoglobulin components in serum, J Immunol Methods, vol.134, pp.273-81, 1990. ,
Modified diffusion blotting for rapid and efficient protein transfer with PhastSystem, Electrophoresis, vol.10, pp.249-53, 1989. ,
Significance of specific epstein-barr virus IgA and elevated IgG antibodies to viral capsid antigens in nasopharyngeal carcinoma patients, J Med Virol, vol.20, pp.329-368, 1986. ,
Cytomegalovirus IgG and IgA serum antibodies in a study of HIV infection and HIV-related diseases in homosexual men, J Med Virol, vol.35, pp.174-183, 1991. ,
Herpes Simplex virus-specific serum immunoglobulin a: detection in patients with primary or recurrent herpes infections and in healthy adults, Infect Immun, vol.1, pp.374-381, 1982. ,
Serum immunoglobulin A antibody to varicella-zoster virus in subjects with primary varicella and herpes zoster infections and in immune subjects, J Clin Microbiology, vol.18, pp.1146-1155, 1983. ,
Comparison of serum IgA and IgG antibodies for detecting helicobacter pylori infection, Int Med, vol.43, pp.548-52, 2004. ,
Viral immunology. Comprehensive serological profiling of human populations using a synthetic human virome, Science, vol.348, p.698, 2015. ,
Serum immunoglobulins (IgG, IgA, IgM) in chronic hepatitis C. A comparison with non-cirrhotic alcoholic liver disease, Hepatogastroenterol, vol.54, pp.2121-2127, 2003. ,
Epstein-Barr virus vaccines, Clin Translat Immunol, vol.4, p.32, 2015. ,
Vaccine development for epstein-barr virus, Adv Exp Med Biol, vol.1045, pp.477-93, 2018. ,
Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors, J Clin Invest, vol.102, pp.1515-1540, 1998. ,
Molecular and cytogenetic characterization of expanded B-cell clones from multiclonal versus monoclonal B-cell chronic lymphoproliferative disorders, Haematologica, vol.99, pp.897-907, 2014. ,
Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia, Blood, vol.94, pp.1840-1847, 1999. ,
Unmutated Ig VH genes are associated with a more aggressive form of chronic lymphocytic leukemia, Blood, vol.94, pp.1848-54, 1999. ,
B-cell chronic lymphocytic leukemia, a clonal disease of B lymphocytes with receptors that vary in specificity for (auto)antigens, Ann N Y Acad Sci, vol.1062, pp.1-12, 2005. ,
Antigen stimulation in the development of chronic lymphocytic leukemia, Postepy Hig Med Dosw, vol.67, pp.1204-1217, 2013. ,
Chronic lymphocytic leukemia cells recognize conserved epitopes associated with apoptosis and oxidation, Mol Med, vol.14, pp.665-74, 2008. ,
Chronic lymphocytic leukemia antibodies with a common stereotypic rearrangement recognize nonmuscle myosin heavy chain IIA, Blood, vol.112, pp.5122-5131, 2008. ,
A new perspective: molecular motifs on oxidized LDL, apoptotic cells, and bacteria are targets for chronic lymphocytic leukemia antibodies, Blood, vol.111, pp.3838-3886, 2008. ,
Characterization of structurally defined epitopes recognized by monoclonal antibodies produced by chronic lymphocytic leukemia B cells, Blood, vol.114, pp.3615-3639, 2009. ,
Antigens in chronic lymphocytic leukemia-implications for cell origin and leukemogenesis, Semin Cancer Biol, vol.20, pp.400-409, 2010. ,
EBV positive diffuse large B cell lymphoma and chronic lymphocytic leukemia patients exhibit increased Anti-dUTPase antibodies, Cancers (Basel), vol.10, p.129, 2018. ,
Common infectious agents and monoclonal B-cell lymphocytosis: a cross-sectional epidemiological study among healthy adults, PLoS ONE, vol.7, p.52808, 2012. ,
Indolent Bcell lymphomas associated with HCV infection: clinical and virological features and role of antiviral therapy, Clin Dev Immunol, p.638185, 2012. ,
IGHV1-69 B cell chronic lymphocytic leukemia antibodies cross-react with HIV-1 and hepatitis C virus antigens as well as intestinal commensal bacteria, PLoS ONE, vol.9, p.90725, 2014. ,
Epstein-Barr virus DNA load in chronic lymphocytic leukemia is an independent predictor of clinical course and survival, Oncotarget, vol.6, pp.18653-63, 2015. ,
Epstein-Barr virus and risk of non-Hodgkin lymphoma in the cancer prevention study-II and a meta-analysis of serologic studies, Int J Cancer, vol.136, pp.108-124, 2015. ,
Aberrant epstein-barr virus antibody patterns and chronic lymphocytic leukemia in a Spanish multicentric case-control study, Infect Agent Cancer, vol.10, p.5, 2015. ,
Epsteinbarr virus micrornas are expressed in patients with chronic lymphocytic leukemia and correlate with overall survival, EBioMedicine, vol.2, pp.572-82, 2015. ,
Gangliosides have a functional role during rotavirus cell entry, J Virol, vol.87, pp.1115-1137, 2013. ,
Incidence of monoclonal gammopathy of undetermined significance and estimation of duration before first clinical recognition, Mayo Clin Proc, vol.87, pp.1071-1080, 2012. ,
Disease associations with monoclonal gammopathy of undetermined significance: a population-based study of 17,398 patients, Mayo Clin Proc, vol.84, pp.685-93, 2009. ,
Regression of a case of multiple myeloma with antiviral treatment in a patient with chronic HCV infection, Leuk Res Rep, vol.2, pp.39-40, 2013. ,
The role of Hepatitis C virus in the development of multiple myeloma: A case study, 60th Annual Meeting of the American Society of Hematology (ASH), vol.132, p.5592, 2018. ,
Role of Bruton's tyrosine kinase in B cells and malignancies, Mol Cancer, vol.17, p.57, 2018. ,
B cell receptor signaling in chronic lymphocytic leukemia, Trends Immunol, vol.34, pp.592-601, 2013. ,
Antiviral drugs for EBV, Cancers (Basel), vol.10, p.197, 2018. ,
Spironolactone blocks epstein-barr virus production by inhibiting EBV SM protein function, Proc Natl Acad Sci, vol.113, pp.3609-3623, 2016. ,
Prevention is the best treatment: the case for understanding the transition from monoclonal gammopathy of undetermined significance to myeloma, Int J Mol Sci, vol.19, p.3621, 2018. ,
Effectiveness of enzyme replacement therapy in 1028 patients with type 1 gaucher disease after 2 to 5 years of treatment: a report from the gaucher registry, Am J Med, vol.113, pp.1150-1156, 2002. ,
Long-term clinical outcomes in type 1 Gaucher disease following 10 years of imiglucerase treatment, J Inherit Metab Dis, vol.36, pp.543-53, 2013. ,
Effect of oral eliglustat on splenomagealy in patients with Gaucher disease type 1 : the ENGAGE randomized clinical trial, JAMA, vol.313, pp.695-706, 2015. ,
Olipudase alfa for treatment of acid sphingomyelinase deficiency (ASMD): safety and efficacy in adults treated for 30 months, J Inherit Metab Dis, vol.41, pp.829-867, 2018. ,
Treating lysosomal storage disorders: what have we learnt?, J Inherit Metab Dis, vol.43, pp.125-157, 2019. ,
Diet-induced obesity promotes a myeloma-like condition in vivo, Leukemia, vol.29, pp.507-517, 2015. ,
Inhibition of UDP-glucosylceramide synthase in mice prevents Gaucher disease-associated B-cell malignancy, J Pathol, vol.235, pp.113-137, 2015. ,
Glucosylsphingosine but not saposin C, is the target antigen in Gaucher disease-associated gammopathy ,
, Mol Genet Metab, vol.129, pp.286-91, 2020.